首站-论文投稿智能助手
典型文献
Activation of Silent Information Regulator 6 Signaling Attenuates Myocardial Fibrosis by Reducing TGFβ1-Smad2/3 Signaling in a Type 2 Diabetic Animal Model
文献摘要:
Objective::Long-term diabetes can result in ventricular hypertrophic remodeling, tissue fibrosis, myocardial metabolic defection, and eventually, heart failure. Silent information regulator 6 (SIRT6) exerts beneficial effects against cardiovascular diseases. This study is aimed to investigate whether the direct regulation of myocardial SIRT6 signaling affects cardiac performance in the case of diabetes. Meanwhile, we sought to explore the underlying mechanisms.Methods::Sprague Dawley (SD) rats were used in this experiment. Briefly, type 2 diabetic animal model was generated by streptozotocin administration along with feeding a high-fat diet. The SD rats were randomly assigned to non-diabetic group, diabetic group, diabetic injected with empty adenoviral vectors group and diabetic injected with adenoviral vectors expressing SIRT6 group ( n = 10, respectively). The animals were kept for another 4 weeks before sacrifice. Cardiac performance was evaluated by echocardiography. Myocardial fibrosis was determined by Masson’s trichrome staining. Myocardial SIRT6 signaling and fibrosis related molecules were measured by western blotting. Results::The diabetic myocardium exhibited markedly enhanced TGFβ1-Smad2/3-induced myocardial fibrosis and reduced SIRT6 and AMP-activated protein kinase (AMPK) signaling. After 4 weeks of SIRT6 adenoviral vector infection, myocardial tissues exhibited markedly enhanced SIRT6 and AMPK signaling. Additionally, myocardial fibrosis and TGFβ1 -Smad2/3 signaling were both attenuated in the diabetic injected with adenoviral vectors expressing SIRT6 group.Conclusions::SIRT6-AMPK signaling suppressed the progression of tissue fibrosis in diabetes mellitus rats by inhibiting TGFβ1 and its downstream effector Smad2/3. SIRT6 might serve as an alternative therapeutic target for diabetes-related cardiovascular diseases.
文献关键词:
AMP-activated protein kinase;Diabetes;Fibrosis;Silent information regulator 6
作者姓名:
Yu Liming;Wang Jian;Dong Xue;Hu Yue;Luo Linyu;Xue Xiaodong;Wang Yang
作者机构:
Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China;Department of Ultrasound, Chinese People's Liberation Army 985 Hospital, Taiyuan, Shanxi 030001, China;Outpatient Department of Liaoning Military Region, General Hospital of Northern Theater Command, Shenyang, Liaoning 110032, China
引用格式:
[1]Yu Liming;Wang Jian;Dong Xue;Hu Yue;Luo Linyu;Xue Xiaodong;Wang Yang-.Activation of Silent Information Regulator 6 Signaling Attenuates Myocardial Fibrosis by Reducing TGFβ1-Smad2/3 Signaling in a Type 2 Diabetic Animal Model)[J].心血管病探索(英文),2022(01):6-12
A类:
defection,adenoviral
B类:
Activation,Silent,Information,Regulator,Signaling,Attenuates,Myocardial,Fibrosis,by,Reducing,TGF,Smad2,Type,Diabetic,Animal,Model,Objective,Long,diabetes,can,result,ventricular,hypertrophic,remodeling,fibrosis,myocardial,metabolic,eventually,heart,failure,information,regulator,SIRT6,exerts,beneficial,effects,against,cardiovascular,diseases,This,study,aimed,investigate,whether,direct,regulation,signaling,affects,cardiac,performance,case,Meanwhile,sought,explore,underlying,mechanisms,Methods,Sprague,Dawley,rats,were,used,this,experiment,Briefly,type,diabetic,was,generated,streptozotocin,administration,along,feeding,high,fat,diet,randomly,assigned,group,injected,empty,vectors,expressing,respectively,animals,kept,another,weeks,before,sacrifice,Cardiac,evaluated,echocardiography,determined,Masson,trichrome,staining,related,molecules,measured,western,blotting,Results,myocardium,exhibited,markedly,enhanced,induced,reduced,activated,protein,kinase,AMPK,After,infection,tissues,Additionally,both,attenuated,Conclusions,suppressed,progression,mellitus,inhibiting,its,downstream,effector,might,serve,alternative,therapeutic,target,Diabetes
AB值:
0.531994
相似文献
Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway
TANG Jing-jing;LI Guang-xi;LIU Zhi-guo;YI Rong;YU Dong;ZHANG Yue-bo;ZHAO Shuang-qiao;WANG Shi-han-Department of Pneumology,Guang'anmen Hospital,Chinese Academy of Chinese Medical Sciences,Beijing(100053),China;Department of Pulmonary and Critical Care Medicine,Mayo Clinic,Rochester,MN 55905,United States;Drug Clinical Trial Agency,Guang'anmen Hospital,Chinese Academy of Chinese Medical Sciences,Beijing(100053),China;Department of Cardiovascular Medicine,Mayo Clinic,Rochester,MN 55905,United States;Department of Gynecology,Guang'anmen Hospital,Chinese Academy of Chinese Medical Sciences,Beijing(100053),China;Department of Cardiovascular Medicine,Guang'anmen Hospital,Chinese Academy of Chinese Medical Sciences,Beijing(100053),China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。